MONTGOMERY, Ala.--(BUSINESS WIRE)--ProEthic Pharmaceuticals, Inc. today announced that Lipofen™ (fenofibrate capsules), a new prescription treatment for cholesterol disorders, is now available in U.S. pharmacies. Lipofen is indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides (TG), and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb). Lipofen is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (Fredrickson Types IV and V hyperlipidemia).
